Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...
After hours: March 14 at 7:59:56 p.m. EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback